Number of the records: 1
Impaired vascular β-adrenergic relaxation in spontaneously hypertensive rats: The differences between conduit and resistance arteries
- 1.0577676 - FGÚ 2024 RIV NL eng J - Journal Article
Valovič, Pavol - Behuliak, Michal - Vaněčková, Ivana - Zicha, Josef
Impaired vascular β-adrenergic relaxation in spontaneously hypertensive rats: The differences between conduit and resistance arteries.
European Journal of Pharmacology. Roč. 958, 5 November (2023), č. článku 176045. ISSN 0014-2999. E-ISSN 1879-0712
R&D Projects: GA MŠMT(CZ) LX22NPO5104; GA ČR(CZ) GA21-03810S
Institutional support: RVO:67985823
Keywords : isoprenaline * β1-agonist dobutamine * β2-agonist salmeterol * femoral artery * resistance mesenteric artery * blood pressure
OECD category: Physiology (including cytology)
Impact factor: 5, year: 2022
Method of publishing: Open access
https://doi.org/10.1016/j.ejphar.2023.176045
It was suggested that impaired β-adrenergic relaxation in spontaneously hypertensive rats (SHR) might contribute to their high blood pressure (BP). Our study was focused on isoprenaline-induced dilatation of conduit femoral or resistance mesenteric arteries and on isoprenaline-induced BP reduction in SHR and Wistar-Kyoto rats (WKY). We confirmed decreased β-adrenergic relaxation of SHR femoral arteries due to the absence of its endothelium-independent component, whereas endothelium-dependent component of β-adrenergic smooth muscle relaxation was similar in both strains. Conversely, isoprenaline-induced relaxation of resistance mesenteric arteries was similar in both strains and this was true for endothelium-dependent and endothelium-independent components. We observed moderately reduced sensitivity of SHR mesenteric arteries to salmeterol (β2-adrenergic agonist) and this strain difference disappeared after endothelium removal. However, there was no difference in mesenteric arteries relaxation by dobutamine (β1-adrenergic agonist) which was independent of endothelium. The increasing isoprenaline doses elicited similar BP decrease in both rat strains, although BP sensitivity to isoprenaline was slightly decreased in SHR. The blockade of cyclooxygenase (indomethacin) and NO synthase (L-NAME) further reduced BP sensitivity to isoprenaline in SHR. On the other hand, salmeterol elicited similar BP decrease in both strains and the blockade of cyclooxygenase and NO synthase increased BP sensitivity to salmeterol in SHR as compared to WKY. In conclusion, attenuated β-adrenergic vasodilatation of conduit arteries of SHR but similar β-adrenergic relaxation of resistance mesenteric arteries from WKY and SHR and their similar BP response to β-adrenergic agonists do not support major role of altered β-adrenergic vasodilatation for high BP in genetic hypertension.
Permanent Link: https://hdl.handle.net/11104/0346806
File Download Size Commentary Version Access 23_0079_0577676.pdf 0 3.5 MB Publisher’s postprint open-access
Number of the records: 1